Metformin Versus Placebo from First Trimester to Delivery in Polycystic Ovary Syndrome: A Randomized, Controlled Multicenter Study
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
CONTEXT: Metformin is widely prescribed to pregnant women with polycystic ovary syndrome (PCOS) in an attempt to reduce pregnancy complications. Metformin is not approved for this indication, and evidence for this practice is lacking. OBJECTIVES: Our objective was to test the hypothesis that metformin, from first trimester to delivery, reduces pregnancy complications in women with PCOS. DESIGN AND SETTING: We conducted a randomized, placebo-controlled, double-blind, multicenter study at 11 secondary care centers. PARTICIPANTS: The participants were 257 women with PCOS, in the first trimester of pregnancy, aged 18-42 yr. INTERVENTION: We randomly assigned 274 singleton pregnancies (in 257 women) to receive metformin or placebo, from first trimester to delivery. MAIN OUTCOME MEASURES: The prevalence of preeclampsia, gestational diabetes mellitus, preterm delivery, and a composite of these three outcomes is reported. RESULTS: Preeclampsia prevalence was 7.4% in the metformin group and 3.7% in the placebo group (3.7%; 95% CI, -1.7-9.2) (P=0.18). Preterm delivery prevalence was 3.7% in the metformin group and 8.2% in the placebo group (-4.4%; 95%, CI, -10.1-1.2) (P=0.12). Gestational diabetes mellitus prevalence was 17.6% in the metformin group and 16.9% in the placebo group (0.8%; 95% CI, -8.6-10.2) (P=0.87). The composite primary endpoint prevalence was 25.9 and 24.4%, respectively (1.5%; 95% CI, -8.9-11.3) (P=0.78). Women in the metformin group gained less weight during pregnancy compared with those in the placebo group. There was no difference in fetal birth weight between the groups. CONCLUSIONS: Metformin treatment from first trimester to delivery did not reduce pregnancy complications in PCOS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Randomized, double-blind, controlled trials comparing metformin with other therapies for ovulation induction in individuals with polycystic ovary syndrome have not demonstrated benefit in preventing spontaneous abortion or GDM (91),”
From 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2024 (2024) · cites this paper as [91]
Citations
Cites
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
Franks, S. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509283331307 · Cited by 2,463
Knochenhauer, E. S., Key, T. J., Kahsar-Miller, M., Waggoner, W., Boots, L. R., & Azziz, R. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.9.5090 · Cited by 1,516
Asunción, M., Calvo, R. M., San Millán, J. L., Sancho, J., Avila, S., & Escobar-Morreale, H. F. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6682 · Cited by 1,318
Metformin versus insulin for the treatment of gestational diabetes
Rowan, J. A., Hague, W. M., Gao, W., Battin, M. R., & Moore, M. P. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707193 · Cited by 1,291
Knochenhauer, E. S. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.9.3078 · Cited by 1,127
Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome
Legro, R. S., Barnhart, H. X., Schlaff, W. D., Carr, B. R., Diamond, M. P., Carson, S. A., Steinkampf, M. P., Coutifaris, C., McGovern, P. G., Cataldo, N. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063971 · Cited by 1,027
A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome
Boomsma, C. M., Eijkemans, M. J. C., Hughes, E. G., Visser, G. H. A., Fauser, B. C. J. M., & Macklon, N. S. (2006) · Human Reproduction Update · doi:10.1093/humupd/dml036 · Cited by 852
Cited by
Items 101–200 of 316
Recurrent Spontaneous Miscarriage: a Comparison of International Guidelines
Vomstein, K., Aulitzky, A., Strobel, L., Bohlmann, M. K., Feil, K., Rudnik‐Schöneborn, S., Zschocke, J., & Tóth, B. (2021) · Geburtshilfe und Frauenheilkunde · doi:10.1055/a-1380-3657 · Cited by 36
“A potential positive effect of taking metformin to reduce the rate of miscarriage has not been shown to date from the current data [38].”
An Update on the Progress of Endometrial Receptivity in Women with Polycystic Ovary Syndrome
Zhao, J., Chen, Q., & Xue, X. (2021) · Reproductive Sciences · doi:10.1007/s43032-021-00641-z · Cited by 37
VANKY, E., DE ZEGHER, F., DÍAZ, M., IBÁÑEZ, L., & CARLSEN, S. M. (2012) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1111/aogs.12015 · Cited by 32
“Furthermore, it may be argued that there was no strong rationale for not pooling second-trimester miscarriage with preterm delivery into a primary end-point in the PregMet study (4).”
BackgroundMethodResultSelf-citationZhao, J., Liu, X., & Zhang, W. (2020) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0603-3394 · Cited by 31
Zheng, J., Shan, P. F., & Gu, W. (2013) · PubMed · doi:10.3275/8932 · Cited by 30
Myo-Inositol Supplementation to Prevent Gestational Diabetes Mellitus
Celentano, C., Matarrelli, B., Mattei, P. A., Pavone, G., Vitacolonna, E., & Liberati, M. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0726-6 · Cited by 33
Valdés, E., Sepúlveda‐Martínez, A., Candia, P., Abusada, N., Orellana, R., Manukian, B., & Cuellar, E. (2018) · Journal of Obstetrics and Gynaecology Research · doi:10.1111/jog.13477 · Cited by 29
Bidhendi Yarandi, R., Behboudi-Gandevani, S., Amiri, M., & Ramezani Tehrani, F. (2019) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-019-0453-7 · Cited by 29
Comments on gestational diabetes mellitus: from pathophysiology to clinical practice
Poulakos, P., Mintziori, G., Tsirou, E., Taousani, E., Savvaki, D., Harizopoulou, V. C., & Goulis, D. G. (2015) · HORMONES · doi:10.14310/horm.2002.1570 · Cited by 42
Elmaraezy, A., Faculty of Medicine, A.-A. U., Ibrahim Abushouk, A., Faculty of Medicine, A. S. U., Emara, A., Faculty of Medicine, A.-A. U., Elshahat, O., Faculty of Medicine, A.-A. U., Ahmed, H., Faculty of Medicine, Z. U., et al. (2017) · International Journal of Reproductive BioMedicine · doi:10.29252/ijrm.15.8.461 · Cited by 29
“Nine full-text articles were excluded as follows: Two single arm/irrelevant trials, three pharmacokinetic analyses, two literature reviews, and two case reports (29-37).”
BackgroundGatford, K. L., Houda, C. M., Lu, Z., Coat, S., Baghurst, P., Owens, J. A., Sikaris, K. A., Rowan, J., & Hague, W. M. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12080 · Cited by 32
“Metformin crosses the placenta, but no teratogenic effects have been reported in women with polycystic ovary syndrome (PCOS) treated with metformin from the first trimester of pregnancy until delivery, including women who were taking metformin at conception [9].”
BackgroundQuotah, O. F., Andreeva, D., Nowak, K. G., Dalrymple, K. V., Almubarak, A., Patel, A. N., Vyas, N. D., Çakır, G. S., Heslehurst, N., Bell, Z., et al. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01217-4 · Cited by 31
“Metformin was used as a pharmacological intervention in eleven RCTs [40, 41, 47, 50, 85–90 , 108].”
BackgroundMethodInfluentialPascual‐Morena, C., Cavero‐Redondo, I., Álvarez‐Bueno, C., Lucerón‐Lucas‐Torres, M., Sanabria‐Martínez, G., Poyatos‐León, R., Rodríguez‐Martin, B., & Martínez‐Vizcaíno, V. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10163490 · Cited by 33
Tosti, G., Barberio, A., Tartaglione, L., Rizzi, A., Leo, M. A. S. D., Viti, L., Sirico, A., Carolis, S. D., Pontecorvi, A., Lanzone, A., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1176623 · Cited by 36
“The study was designed as a follow-up of two randomized, placebo-controlled studies [the pilot study (33) and the PregMet study (34)], and included 93 children with a mean age of 7.”
BackgroundMethodInfluentialWei, D., Zhang, B., Shi, Y., Zhang, L., Zhao, S., Du, Y., Xu, L., Legro, R. S., Zhang, H., & Chen, Z. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01294 · Cited by 32
Andræ, F., Abbott, D. H., Stridsklev, S., Schmedes, A., Odsæter, I. H., Vanky, E., & Salvesen, Ø. O. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa605 · Cited by 31
“Adherence to study medication during pregnancy was high, and the original study was conducted in accordance with “Good Clinical Practice Principles” (24).”
BackgroundMethodSelf-citationThe Hirsute Woman: Challenges in Evaluation and Management
Paparodis, R. D., & Dunaif, A. E. (2011) · Endocrine Practice · doi:10.4158/ep11117.ra · Cited by 27
Growth Restriction in the Offspring of Mothers With Polycystic Ovary Syndrome
Talmo, M. S. A., Fløysand, I. S., Nilsen, G. Ø., Løvvik, T. S., Ødegård, R. A., Júlíusson, P. B., Vanky, E., & Simpson, M. R. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.30543 · Cited by 32
Self-citationAlbaghdadi, A. J. H., & Kan, F. W. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062872 · Cited by 28
“Metformin - Improves glucose intolerance [87,88] - Modulates uterine/endometrial ER and PGR expressional irregularities [89] - Suppresses AR expression and normalizes the AR-mediated gene transcription [91,124] - May improve endometrial receptivity defects and improves uterine vascularity and subendometrial blood flow…”
BackgroundMethodMetformin in gestational diabetes: An emerging contender
Singh, A. K., & Singh, R. (2015) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.149317 · Cited by 31
“[40] Most recent RCT ( n = 320) by Morin Papunen et al ., suggested higher live birth rate in metformin arm when it was continued from pre‑conception till first trimester ( P = 0.014) [Table 7].”
InfluentialGregg, B. E., Botezatu, N., Brill, J. D., Hafner, H., Vadrevu, S., Satin, L. S., Alejandro, E. U., & Bernal‐Mizrachi, E. (2018) · Scientific Reports · doi:10.1038/s41598-018-23965-4 · Cited by 25
Sciacca, L., Bianchi, C., Burlina, S., Formoso, G., Manicardi, E., Sculli, M. A., & Resi, V. (2023) · Acta Diabetologica · doi:10.1007/s00592-023-02137-5 · Cited by 33
“The study did not assess pregnancy loss and it lacked the statistical power to detect changes in the occurrence of GDM [38].”
BackgroundRojas, J., Chávez-Castillo, M., & Bermúdez, V. (2014) · International Journal of Reproductive Medicine · doi:10.1155/2014/797681 · Cited by 28
Zhu, D., Chen, Y., Huang, J., Deng, H., Shen, X., Lu, D., & Xu, L. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-909 · Cited by 28
“Previous studies have reported that PCOS is associated with severe pregnancy complications, including a threefold increased risk of GDM, a threefold to fourfold increased risk of PIH and preeclampsia, and a twofold increased risk of preterm delivery (28,29,31).”
Metformin in Gestational Diabetes Mellitus: To Use or Not to Use, That Is the Question
Tocci, V., Mirabelli, M., Salatino, A., Sicilia, L., Giuliano, S., Brunetti, F. S., CHIEFARI, E. D., Sarro, G. D., FOTI, D. P., & Brunetti, A. (2023) · Pharmaceuticals · doi:10.3390/ph16091318 · Cited by 39
“The long-term effects of metformin on children’s cardiometabolic profiles were also examined in a follow-up study of the PregMet study, an RCT comparing metformin versus placebo for the treatment of PCOS women during pregnancy [83].”
BackgroundInfluentialManagement of Polycystic Ovary Syndrome in India
Malik, S., Jain, K., Talwar, P., Prasad, S., Dhorepatil, B., Devi, G., Khurana, A., Bhatia, V., Chandiok, N., Kriplani, A., et al. (2014) · Fertility Science and Research · doi:10.4103/2394-4285.146798 · Cited by 43
Exposure of mouse embryonic pancreas to metformin enhances the number of pancreatic progenitors
Gregg, B. E., Elghazi, L., Alejandro, E. U., Smith, M. R., Blandino-Rosano, M., El‐Gabri, D., CRAS-MÉNEUR, C. M. H., & Bernal‐Mizrachi, E. (2014) · Diabetologia · doi:10.1007/s00125-014-3379-5 · Cited by 25
“However, a potentially relevant clinical scenario is one in which women are treated for polycystic ovary syndrome from the first trimester to delivery, as described in some studies [24, 51–55].”
Polycystic Ovary Syndrome: Current Infertility Management
Aubuchon, M., & Legro, R. S. (2011) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0b013e3182353c98 · Cited by 42
Valdimarsdottir, R., Valgeirsdottir, H., Wikström, A., Kallak, T. K., Elenis, E., Axelssön, O., Ubhayasekhera, K., Bergquist, J., Piltonen, T., Pigny, P., et al. (2019) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2019.02.004 · Cited by 32
Xu, Q., & Xie, Q. (2019) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-019-05124-w · Cited by 29
Continuous Glucose Monitoring During Pregnancy in Women With Polycystic Ovary Syndrome
Dmitrovic, R., Katcher, H. I., Kunselman, A. R., & Legro, R. S. (2011) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e31822c887f · Cited by 23
(2017) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.14764 · Cited by 31
Androgens and antimüllerian hormone in mothers with polycystic ovary syndrome and their newborns
Vanky, E., & Carlsen, S. M. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.11.021 · Cited by 25
Self-citationFougner, S. L., Vanky, E., Løvvik, T. S., & Carlsen, S. M. (2021) · PLOS ONE · doi:10.1371/journal.pone.0254895 · Cited by 23
Self-citationCao, Q., Hu, Y., Fu, J., Huang, X., Wu, L., Zhang, J., & Huang, W. (2021) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.15044 · Cited by 26
“Two(17,19) were excluded for being published using the same cohort with other included studies.(9,11) Twenty were found not RCTs.”
BackgroundMethodResultInfluentialCan a Dietary Supplement Prevent Gestational Diabetes Mellitus?
Coustan, D. R. (2013) · Diabetes Care · doi:10.2337/dc12-2505 · Cited by 24
“While metformin, an insulin-sensitizing drug, initially appeared to prevent GDM in nonrandomized cohort studies, a double-blind RCT did not demonstrate efficacy (8).”
BackgroundPregnancy complications in infertile patients with polycystic ovary syndrome: updated evidence
Palomba, S., Falbo, A., Daolio, J., Battaglia, F. A., & La Sala, G. B. (2018) · Minerva Ginecologica · doi:10.23736/s0026-4784.18.04230-2 · Cited by 22
Effects of metformin treatment on pregnancy outcomes in patients with polycystic ovary syndrome
Raperport, C., Chronopoulou, E., & Homburg, R. (2021) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2021.1889366 · Cited by 26
Immunomodulatory Effects of Metformin Treatment in Pregnant Women With PCOS
Ryssdal, M., Vanky, E., Stokkeland, L. M. T., Jarmund, A. H., Steinkjer, B., Løvvik, T. S., Madssen, T. S., Iversen, A., & Giskeødegård, G. F. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad145 · Cited by 24
Self-citationEfficacy of metformin in pregnant obese women: a randomised controlled trial
Chiswick, C. A., Reynolds, R. M., Denison, F. C., Whyte, S., Drake, A. J., Newby, D. E., Walker, B. R., Forbes, S., Murray, G. D., Quenby, S. M., et al. (2015) · BMJ Open · doi:10.1136/bmjopen-2014-006854 · Cited by 21
“throughout pregnancy, showed no significant differences in the prevalence of preterm birth, pre-eclampsia and gestational diabetes.(31) There was also no difference in birth weights of the babies in the two groups.”
BackgroundRESISTENCIA A LA INSULINA: VERDADES Y CONTROVERSIAS
Felipe Pollak, C. (2016) · Revista Médica Clínica Las Condes · doi:10.1016/j.rmclc.2016.04.006 · Cited by 19
“Si bien reduce los niveles de andrógenos su uso no se justifica en todas las pacientes (26-28).”
BackgroundIs it worth treating gestational diabetes: if so, when and how?
Vääräsmäki, M. (2016) · Diabetologia · doi:10.1007/s00125-016-3976-6 · Cited by 22
“Metformin was first used during pregnancy to treat type 2 diabetes [32, 33] and thereafter the main context of its use during pregnancy largely consisted of studies that included women with polycystic ovary syndrome [34, 35].”
MethodDoes Metformin Treatment During Pregnancy Modify the Future Metabolic Profile in Women With PCOS?
Underdal, M. O., Stridsklev, S., Oppen, I. H., Høgetveit, K., Andersen, M., & Vanky, E. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00485 · Cited by 21
Self-citationPharmacotherapeutic management of comorbid polycystic ovary syndrome and diabetes
Ortiz-Flores, A. E., Luque‐Ramírez, M., & Escobar-Morreale, H. F. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1528231 · Cited by 23
“betes prevention and management [72,73], furthermore when metformin use in pregnant women with PCOS has been”
BackgroundAsimakopoulos, G., Pergialiotis, V., Anastasiou, E., Antsaklis, P. G., Theodora, M., Vogiatzi, E., Kallergi, A., Sindos, M., Loutradis, D., & Daskalakis, G. J. (2020) · Trials · doi:10.1186/s13063-020-04561-2 · Cited by 19
Hanem, L. G. E., Salvesen, Ø. O., Madsen, A., Sagen, J. V., Mellgren, G., Júlíusson, P. B., Carlsen, S. M., Vanky, E., & Ødegård, R. A. (2021) · PLoS ONE · doi:10.1371/journal.pone.0257186 · Cited by 21
Self-citationAfamin predicts gestational diabetes in polycystic ovary syndrome patients preconceptionally
Köninger, A., Iannaccone, A., Hajder, E., Frank, M., Schmidt, B., Schleußner, E., Kimmig, R., Gellhaus, A., & Dieplinger, H. (2019) · Endocrine Connections · doi:10.1530/ec-19-0064 · Cited by 18
Huang, S., Hu, M., Ng, E. H. Y., Stener‐Victorin, E., Zheng, Y., Wen, Q., Wang, C., Lai, M., Li, J., Gao, X., et al. (2020) · Trials · doi:10.1186/s13063-020-4154-1 · Cited by 19
Chatzakis, C., Tsakmaki, E., Psomiadou, A., Charitakis, N., Eleftheriades, M. I., Dinas, K. D., Goulis, D. G., & Sotiriadis, A. (2022) · Fertility and Sterility · doi:10.1016/j.fertnstert.2021.12.027 · Cited by 22
do Nascimento, I. B., Dienstmann, G., de Souza, M. L. R., Fleig, R., Hoffmann, C. B. P. C., & Silva, J. C. (2018) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1055/s-0038-1675214 · Cited by 21
Lin, S., Chang, S., Kuo, C., Lin, W., Chiou, M., & Huang, Y. (2020) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-020-03207-0 · Cited by 20
Insulin Resistance in Pregnancy: Implications for Mother and Offspring
Hernandez, T. L., Friedman, J. E., & Barbour, L. A. (2019) · Contemporary Endocrinology · doi:10.1007/978-3-030-25057-7_5 · Cited by 25
Cheshire, J., Garg, A., Smith, P., Devall, A., Coomarasamy, A., & Dhillon‐Smith, R. K. (2025) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2025.05.038 · Cited by 20
Thyroid Status During Pregnancy in Women With Polycystic Ovary Syndrome and the Effect of Metformin
Trouva, A., Alvarsson, M., Calissendorff, J., Åsvold, B. O., Vanky, E., & Hirschberg, A. L. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.772801 · Cited by 17
Self-citationAnthropometrics of neonates born to mothers with PCOS with metformin or placebo exposure in utero
Nilsen, G. Ø., Simpson, M. R., Hanem, L. G. E., Løvvik, T. S., Ødegård, R. A., Stokkeland, L. M. T., Andersen, M., Júlíusson, P. B., & Vanky, E. (2023) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.14637 · Cited by 18
Self-citationHow Metformin Acts in PCOS Pregnant Women
Romualdi, D., De Cicco, S., Gagliano, D., Busacca, M., Campagna, G., Lanzone, A., & Guido, M. (2013) · Diabetes Care · doi:10.2337/dc12-2071 · Cited by 16
“By contrast, and in keeping with our data, the only previous landmark, randomized, placebo-controlled study published to date failed to document a positive effect of metformin on the risk of GD in women with PCOS (22).”
ResultHbA1c as screening for gestational diabetes mellitus in women with polycystic ovary syndrome
Odsæter, I. H., Åsberg, A., Vanky, E., & Carlsen, S. M. (2015) · BMC Endocrine Disorders · doi:10.1186/s12902-015-0039-9 · Cited by 19
“The current study used data from the previously reported PregMet (Metformin treatment in pregnant women with PCOS) study which was a prospective, randomised, double-blind, multicentre trial in women with PCOS comparing 2000 mg metformin daily against placebo from first trimester to delivery [23].”
MethodSelf-citationKovanci, E., & Buster, J. E. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781139628938.068 · Cited by 18
Fetal Growth and Birth Anthropometrics in Metformin-Exposed Offspring Born to Mothers With PCOS
Hjorth‐Hansen, A. K., Salvesen, Ø. O., Hanem, E., Eggebø, T. M., Salvesen, K., Vanky, E., & Ødegård, R. A. (2018) · Yearbook of pediatric endocrinology · doi:10.1530/ey.15.2.21 · Cited by 15
Self-citationWhat is new in the landscape of insulin-sensitizing agents for polycystic ovary syndrome treatment
Romualdi, D., Versace, V., & Lanzone, A. (2020) · Therapeutic Advances in Reproductive Health · doi:10.1177/2633494120908709 · Cited by 20
Management of Women with Polycystic Ovary Syndrome During Pregnancy
Valent, A. M., & Barbour, L. A. (2021) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2020.10.005 · Cited by 17
Deussen, A. R., Louise, J., & Dodd, J. M. (2022) · Pediatric Obesity · doi:10.1111/ijpo.12974 · Cited by 16
Helseth, R., Vanky, E., Salvesen, Ø. O., & Carlsen, S. M. (2013) · European Journal of Endocrinology · doi:10.1530/eje-12-1107 · Cited by 18
Self-citationZhao, Q., & He, J. (2022) · Gynecological Endocrinology · doi:10.1080/09513590.2022.2080194 · Cited by 17
“Five meta-analyses analyzed the efficacy of metformin in pregnant women with PCOS: Zhao [15] (6 studies: 2 RCTs [30,33], 2 PCs [35,38], 1 retrospective study [10], and 1 study without a control group [41]), Zeng [16] (13 studies: 5 RCTs [29–33], 6 PCs [34,36–40], and 2 retrospective studies [10,42]), Feng [17] (5 stud…”
BackgroundA narrative review of metformin in pregnancy: Navigating benefit and uncertainty
McEvoy, R. P., Newman, C., Egan, A. M., & Dunne, F. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16361 · Cited by 19
“21,73,109,110,120 However, with the exception of the first PregMet trial, 49 the incidence of HDP was not listed as a primary outcome in any of these large RCTs, and they may all have been under-powered to detect a true therapeutic effect.”
InfluentialScreening and management of major endocrinopathies during pregnancy: an update
Paschou, S. Α., Bletsa, E., Papazisi, M., Mili, N., Kanouta, F., Kassi, G., Ψαλτοπούλου, Θ., Goulis, D. G., & Lambrinoudaki, I. V. (2022) · Endocrine · doi:10.1007/s12020-022-03237-y · Cited by 16
Fu, J. M., Tabbara, N., TOMLINSON, G. A., Murphy, K. E., Hamilton, J. K., & Feig, D. S. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-088653 · Cited by 16
Adiponectin: Are Measurements Clinically Useful in Pregnancy?
Mouzon, S. H., & Catalano, P. M. (2013) · Diabetes Care · doi:10.2337/dc12-2532 · Cited by 15
“Furthermore, metformin treatment of womenwith polycystic ovary syndrome in early pregnancy did not decrease the risk of later GDM (28).”
BackgroundResearch progress of metformin in gestational diabetes mellitus: a narrative review
Ouyang, H., Al-Mureish, A., & Wu, N. (2021) · Annals of Palliative Medicine · doi:10.21037/apm-21-192 · Cited by 19
“A prospective, randomized, multicenter trial in pregnant women with PCOS aimed to determine the preventive effects of metformin exposure from first trimester to delivery on pregnancy complications found no significant differences between metformin and placebo in major outcomes related to pregnancy or neonates (96).”
BackgroundShould metformin be included in fertility treatment of PCOS patients?
Haas, J., & Bentov, Y. (2017) · Medical Hypotheses · doi:10.1016/j.mehy.2017.01.012 · Cited by 14
Drugs to Control Diabetes During Pregnancy
Feghali, M. N., Umans, J. G., & Catalano, P. M. (2019) · Clinics in Perinatology · doi:10.1016/j.clp.2019.02.005 · Cited by 16
Metformin during Pregnancy in Polycystic Ovary Syndrome: Another Vitamin Bites the Dust
Legro, R. S. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2301 · Cited by 15
Panidis, D., Τζιόμαλος, Κ., Papadakis, E. P., Kandaraki, E., & Katsikis, I. (2013) · HORMONES · doi:10.14310/horm.2002.1403 · Cited by 13
Stridsklev, S., Carlsen, S. M., Salvesen, Ø. O., Clemens, I., & Vanky, E. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3227 · Cited by 14
“The present study is a substudy of the Metformin Treatment in Pregnant PCOS Women (PregMet) study, which was a prospective, randomized, double-blind, multicenter trial, comparing 2000 mg metformin daily with placebo (27).”
MethodSelf-citationDungan, J. S. (2011) · Yearbook of Obstetrics Gynecology and Women s Health · doi:10.1016/j.yobg.2011.06.070 · Cited by 12
Yu, H., Sun, J., & Hu, H. (2023) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-023-03380-z · Cited by 13
Focus on Metformin: Its Role and Safety in Pregnancy and Beyond
Newman, C., Rabbitt, L., Ero, A., & Dunne, F. (2023) · Drugs · doi:10.1007/s40265-023-01899-0 · Cited by 14
“Studies from northern Europe have shown less GWG but no changes in foetal or other maternal outcomes [65].”
BackgroundMayadunne, T., Saadati, S., Asmelash, D., Mason, T., Vanky, E., Teede, H. J., & Mousa, A. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16418 · Cited by 17
“22,28,29 However, other studies report no effects of metformin on foetal growth or the duration of gestation, 30 with some suggesting reduced miscarriage and prolonged gestation with metformin compared with placebo.”
Self-citationLøvvik, T. S., Stridsklev, S., Carlsen, S. M., Salvesen, Ø. O., & Vanky, E. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3498 · Cited by 13
Self-citationUnderdal, M. O., Salvesen, Ø. O., Henriksen, A. H., Andersen, M., & Vanky, E. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz053 · Cited by 14
Self-citationPCOS – what matters in early pregnancy?– data from a cross‐sectional, multicenter study
Vanky, E., Stridsklev, S., Skogøy, K., Kleggetveit, O., Hjelle, S., von Brandis, P., Eikeland, T., Flo, K., Berg, K. F., Bunford, G., et al. (2011) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/j.1600-0412.2010.01064.x · Cited by 11
“The PregMet study was a prospective, randomized, double-blind, multicenter trial comparing metformin 2000 mg daily with placebo (7).”
MethodSelf-citationProlactin and breast increase during pregnancy in PCOS: linked to long-term metabolic health?
Underdal, M. O., Salvesen, Ø. O., Schmedes, A., Andersen, M., & Vanky, E. (2019) · European Journal of Endocrinology · doi:10.1530/eje-19-0002 · Cited by 11
Self-citationMolin, J., Vanky, E., Løvvik, T. S., Dehlin, E., & Bixo, M. (2021) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.17042 · Cited by 11
“All participants followed essentially the same protocol.(7,8) Thirty- six of the women with PCOS were randomised”
BackgroundSelf-citationPalomba, S., Santagni, S., Daolio, J., Gibbins, K. J., Battaglia, F. A., Sala, G. B. L., & Silver, R. M. (2017) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-017-4572-9 · Cited by 11
Macklon, N. (2011) · BMJ · doi:10.1136/bmj.d6407 · Cited by 11
Chiswick, C. A., Reynolds, R. M., Denison, F. C., Drake, A. J., Forbes, S., Newby, D. E., Walker, B. R., Quenby, S. M., Wray, S., Weeks, A. D., et al. (2016) · Efficacy and Mechanism Evaluation · doi:10.3310/eme03070 · Cited by 11
García-Contreras, C., Vázquez-Gómez, M., Pacheco, J. L. P., Heras-Molina, A., Encinas, T., Astiz, S., & Gonzalez‐Bulnes, A. (2020) · Pharmaceuticals · doi:10.3390/ph13110363 · Cited by 10
“A similar effect was described in human pregnancies affected by polycystic ovarian syndrome (PCOS) and therefore treated with metformin [21,22].”
BackgroundDienstmann, G., do Nascimento, I. B., Sales, W. B., de Souza, M. L. R., da Silva, G. D., de Oliveira, L. C., & Silva, J. C. (2020) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2020.09.005 · Cited by 10
Lovell, H., Mitchell, A., Ovadia, C., Pitrelli, N., Briley, A. L., Singh, C. M., Marschall, H., Cruickshank, K. J., Murphy, H. R., Seed, P. T., et al. (2022) · Trials · doi:10.1186/s13063-022-06462-y · Cited by 11
Bassols, J., Megía, A., Soriano‐Rodríguez, P., Díaz, M., Prats‐Puig, A., Gifre, M., Simón‐Muela, I., Torrent, S., Borrell, A. C., Riera-Socasau, J.-C., et al. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.04.037 · Cited by 10
Association of polycystic ovary syndrome with multiple health factors and adverse pregnancy outcomes
Markin, L. B., Коrytko, О. О., Fartushok, T. V., Fartushok, N. V., Fedevych, Y. M., Dzhalilova, E. A., & Zhykovskiy, V. (2023) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.19.2.2023.1259 · Cited by 14
Mogoş, R. A., Gheorghe, L., Cărăuleanu, A., Vasilache, I.-A., Munteanu, I.-V., Mogoş, S. J., Solomon-Condriuc, I. P., Băean, M.-L., Socolov, D. G., Adam, A.-M., et al. (2024) · Medicina · doi:10.3390/medicina60081298 · Cited by 15
“A multicenter randomized controlled trial (RCT) was conducted to evaluate the effectiveness of metformin in minimizing pregnancy complications in 274 pregnancies of women with polycystic ovary syndrome [40].”
MethodMetformin administration during pregnancy — current insight
Skibińska, M., Żurawska-Kliś, M., Krekora, M., & Cypryk, K. (2021) · Ginekologia Polska · doi:10.5603/gp.a2020.0149 · Cited by 8
“As for the continuation of metformin therapy in women suffering from PCOS, insulin resistance, glucose intolerance or even diabetes type 2 who are at the beginning of pregnancy, there is still a limited number of studies regarding such patients.”
BackgroundInfluentialHelseth, R., Vanky, E., Stridsklev, S., Vogt, C. M., & Carlsen, S. M. (2014) · European Journal of Endocrinology · doi:10.1530/eje-13-0859 · Cited by 9
Self-citationMetformin and Pregnancy Outcomes: Evidence Gaps and Unanswered Questions
González, C. D., Alvariñas, J., Bagnes, M. F. G., & Girolamo, G. D. (2018) · Current Clinical Pharmacology · doi:10.2174/1574884714666181224151116 · Cited by 10
Endocrine Diseases of Pregnancy
Edlow, A. G., & Norwitz, E. R. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-47912-7.00027-5 · Cited by 10
COMPLICATIONS OF PREGNANCY IN WOMEN WITH POLYCYSTIC OVARIAN SYNDROME
Azizia, M., & Hardiman, P. (2011) · Fetal and Maternal Medicine Review · doi:10.1017/s0965539511000088 · Cited by 7
Is metformin safe in pregnancy: a focus on offspring outcomes
Malek, R., & Davis, S. N. (2024) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2024.2424410 · Cited by 11
“The second large, long-term offspring follow-up is from the PregMet study of Norway [13].”
Boroumand, F., Ghayur, S., Gharaaghaji, R., & Vazifekhah, S. (2022) · Journal of Obstetrics Gynecology and Cancer Research · doi:10.30699/jogcr.7.6.524 · Cited by 7
“Another study with a smaller statistical population did not find metformin use effective in reducing the birth weight of mothers with a history of non-obese polycystic ovaries (21).”
BackgroundMyoinositol Supplementation on Insulin Resistance in Gestational Diabetes
Corrado, F., & Santamaria, A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-800093-9.00019-3 · Cited by 8
Metadata
- Authors
- Vanky, E., Stridsklev, S., Heimstad, R., Romundstad, P., Skogøy, K., Kleggetveit, O., Hjelle, S., von Brandis, P., Eikeland, T., Flo, K., Berg, K. F., Bunford, G., Lund, A., Bjerke, C., Almås, I., Berg, A. H., Danielson, A., Lahmami, G., & Carlsen, S. M.
- Affiliations
- Norwegian University of Science and Technology (NO)
- St Olav's University Hospital (NO)
- Department of Public Health (P.R.) Institute of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, 7489 Trondheim, Norway;
- Sentral Hospital of Northern Norway (K.S.), 8092 Bodø, Norway;
- Elvebredden Gynekologpraksis (O.K.), 4630 Kristiansand, Norway;
- Ålesund Hospital (NO)
- Stavanger University Hospital (P.v.B.), 4011 Stavanger, Norway;
- Haugesund Hospital (T.E.), 5504 Haugesund, Norway;
- UiT The Arctic University of Norway (NO)
- Drammen Hospital (NO)
- Ringerike Hospital (G.B.), 5311 Hønefoss, Norway;
- University of Bergen (NO)
- Lillehammer Hospital (C.B., A.H.B., A.D.), 2629 Lillehammer, Norway
- Buskerud Hospital (K.F.B., I.A.), 3004 Drammen, Norway;
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2010-12-01
- Volume
- 95
- Issue
- 12
- Pages
- E448-E455
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1986803895
- Cited by
- 315
- References
- 28
- Citations by year
- 2026: 6 · 2025: 12 · 2024: 18 · 2023: 20 · 2022: 19 · 2021: 22 · 2020: 19 · 2019: 23 · 2018: 24 · 2017: 16 · 2016: 21 · 2015: 17 · 2014: 25 · 2013: 30 · 2012: 20
- FWCI
- 28.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Helse Midt-Norge
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
- Keywords
- metformin, polycystic ovary syndrome, pregnancy complications, preeclampsia, gestational diabetes mellitus, preterm birth, gestational weight gain, birth weight, first trimester
- MeSH terms
- Adult, Blood Pressure, Double-Blind Method, Female, Heart Rate, Humans, Metformin, Patient Compliance, Placebos, Polycystic Ovary Syndrome, Pre-Eclampsia, Pregnancy, Pregnancy Complications, Pregnancy Trimester, First, Random Allocation, Diabetes, Gestational, Delivery, Obstetric
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.